TABLE 3.
Within-group effect |
Between-group effect (time × group) |
||||||||||||||
T0 |
T1a |
ES | T2a |
ES | T1-T0b |
T2-T0b |
F | p |
ES |
||||||
Mean | SD | Mean | SD | d | Mean | SD | d | Mean | SE | Mean | SE | Partial η2 | |||
BAI | 3.38 | 0.06 | 0.31 | ||||||||||||
I-BMS | 8.44 | 4.56 | 3.33** | 2.96 | –1.33 | 3.78* | 3.15 | –1.13 | −5.11* | 1.37 | –4.67 | 1.40 | |||
Control | 5.11 | 4.96 | 4.44 | 5.41 | –0.13 | 3.33* | 4.87 | –0.36 | –0.67 | 1.37 | –1.78 | 1.40 | |||
BDI | 8.04 | 0.00 | 0.52 | ||||||||||||
I-BMS | 13.11 | 8.43 | 3.89*** | 3.72 | –1.24 | 4.11** | 3.18 | –1.40 | −9.22** | 1.79 | –9.00 | 2.19 | |||
Control | 10.44 | 7.11 | 9.22 | 6.12 | –0.17 | 8.00* | 6.31 | –0.35 | –1.22 | 1.79 | –2.44 | 2.19 | |||
Health Related Quality of Life (PCOSQ) | |||||||||||||||
Total | 10.32 | 0.00 | 0.58 | ||||||||||||
I-BMS | 150.44 | 19.88 | 170.33** | 19.27 | 1.02 | 174.78** | 24.29 | 1.08 | 19.89*** | 5.09 | 24.33* | 6.79 | |||
Control | 131.78 | 29.64 | 118.11** | 27.57 | –0.47 | 134.67 | 33.68 | –0.09 | –13.67 | 5.09 | 2.89 | 6.79 | |||
Hirsutism | 2.64 | 0.10 | 0.26 | ||||||||||||
I-BMS | 32.00 | 2.78 | 33.33 | 2.06 | 0.51 | 33.89 | 2.21 | 0.75 | 1.33* | 1.55 | 1.89* | 1.59 | |||
Control | 27.22 | 7.93 | 23.56 | 10.21 | –0.38 | 26.00 | 9.50 | 0.14 | –3.67 | 1.55 | –1.22 | 1.59 | |||
Acne | 3.06 | 0.08 | 0.29 | ||||||||||||
I-BMS | 24.78 | 3.46 | 26.22 | 2.91 | 0.45 | 26.44 | 2.79 | 0.52 | 1.44* | 1.19 | 1.67* | 1.22 | |||
Control | 18.00 | 8.99 | 15.67 | 7.50 | –0.26 | 17.89 | 8.09 | –0.01 | –2.33 | 1.19 | –0.11 | 1.22 | |||
Obese | 2.38 | 0.13 | 0.24 | ||||||||||||
I-BMS | 24.22 | 10.85 | 28.33 | 8.44 | 0.40 | 28.00* | 9.14 | 0.34 | 4.11* | 1.67 | 3.78 | 1.31 | |||
Control | 19.00 | 8.00 | 18.00 | 7.53 | –0.13 | 20.89 | 10.03 | 0.18 | –1.00 | 1.66 | 1.89 | 1.31 | |||
Infertile | 1.39 | 0.28 | 0.16 | ||||||||||||
I-BMS | 9.89 | 4.86 | 11.56 | 3.25 | 0.39 | 13.67 | 4.80 | 0.78 | 1.67 | 1.18 | 3.78 | 1.44 | |||
Control | 11.11 | 5.16 | 10.33 | 4.64 | –0.15 | 11.67 | 4.74 | 0.11 | –0.78 | 1.18 | 0.56 | 1.44 | |||
Menstrual | 1.07 | 0.37 | 0.13 | ||||||||||||
I-BMS | 25.44 | 4.75 | 28.44 | 6.54 | 0.43 | 29.11 | 4.26 | 0.75 | 3.00 | 2.15 | 3.67 | 1.76 | |||
Control | 21.89 | 6.09 | 20.67 | 5.79 | –0.20 | 22.56 | 5.22 | 0.11 | –1.22 | 2.15 | 0.67 | 1.76 | |||
Emotion | 5.88 | 0.01 | 0.44 | ||||||||||||
I-BMS | 34.11 | 11.33 | 42.44* | 5.00 | 0.82 | 43.67* | 8.52 | 0.94 | 8.33** | 2.65 | 9.56 | 3.01 | |||
Control | 34.56 | 10.68 | 29.89 | 8.36 | –0.46 | 35.67 | 11.68 | 0.10 | –4.67 | 2.65 | 1.11 | 3.01 |
BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory-II; PCOSQ, Polycystic Ovary Syndrome Questionnaire; SD, standard deviation; ES, effect size; SE, standard error. aWithin-group difference using paired t-test. bBetween-group difference using independent t-test. *p < 0.05; **p < 0.01; ***p < 0.001.